SCHEMBL21377993

SCHEMBL21377993

N#Cc1c(-n2c3ccccc3c3ccccc32)c(-n2c3ccccc3c3ccccc32)c(-c2cccc(-n3c4ccccc4c4ccccc43)c2)c(-n2c3ccccc3c3ccccc32)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 6/20 0.35
HPGD P15428 3/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTR3A P46098 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP11B2 P19099 1/20 0.34
EGFR P00533 1/20 0.33
SRC P12931 1/20 0.33
PDE9A O76083 1/20 0.33
PDE1C Q14123 1/20 0.33
RXFP1 Q9HBX9 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
MAPK1 P28482 1/20 0.33
STAT3 P40763 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24624452 0.94 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL24623462 0.93 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL24623436 0.90 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL21378015 0.89 GABRA1 (0.34) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL21378077 0.89 CYP11B2 (0.40) KDM4EATML3MBTL1CYP11B2NCOA3
SCHEMBL23979238 0.89 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL21884022 0.89 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL21378066 0.89 CYP11B2 (0.35) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21559973 0.88 KDM4E (0.47) KDM4EATML3MBTL1ALDH1A1HPGD
SCHEMBL21378067 0.88 KDM4E (0.49) KDM4EATML3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608333-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-03-21 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885ATM 1817/4885L3MBTL1 1198/4885
US-11608333-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885ATM 1817/4885L3MBTL1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.